Community
Written by: CDO Magazine Bureau
Updated 6:44 PM UTC, Fri November 3, 2023
A core group of Boston’s forward-thinking senior data executives gathered at CDO Magazine’s executive boardroom dinner October 24 to network, peer mentor, and share their perspectives on “GenAI: How You Are Exploring or Using It.”
Data leaders from various sectors, including government, pharmaceutical, financial services, and biotech discussed topics ranging from how to create business value and prioritize investments to how to manage expectations, address governance, and upskill human resources, moderated by Matt Sweetnam, AHEAD Chief Architect.
Leaders on CDO Magazine’s Global Editorial Board shared several key points and takeaways. Krishna Valluru, Fidelity Investments VP of Advanced Data Analytics, sums up what his peers are facing: “It’s become apparent that they are encountering significant challenges when it comes to utilizing data for GenAI use cases.”
While actively considering ethical implications within their models, he says the most prominent obstacles stem from data quality, trust, and skill, with a focus on data preprocessing. Valluru adds that many use cases they face revolve around content generation for marketing, FDA regulatory filings, and summarization.
Sravan Kasarla, Thrivent Chief Data Officer and Head of AI/ML, warns practitioners to be careful with GenAI, saying, “Let’s not make it a hammer you’re going to use now and everything becomes a nail. Make sure that you’re applying it for the right use case.” He elaborates the importance of:
Specifically, Kasarla recommends, “You create a layer of abstraction where you can use the power of the large language model, whether it is the best NLP or just search and summarization. But, design it so that you can abstract a way to a different, more powerful, or better model.”
He adds, “The use cases which are the most successful, in my opinion, are leveraging the NLP power of the large language model for search and summarization, and text creation. Know your data that you are passing through a large language model to have a better context and results you can stand behind.”
Mamta Singh, Commonwealth of Massachusetts Deputy Chief Data Officer, suggests, “While there’s no denying the potential hitches in terms of ethics and legality, the establishment of a GenAI (generative AI) governance committee can address these concerns. A significant boon of GenAI lies in its ability to eliminate repetitive tasks, thus liberating human resources for more meaningful endeavors.
“While the journey of integrating GenAI into our lives will come with its set of challenges, with the proper measures and intentions, it promises a brighter, more efficient future,” Singh adds.
According to Barbara Latulippe, Takeda Head of Enterprise Data, key takeaways were:
Data executives attending the CDO Magazine Boston Executive Boardroom Dinner included:
Sravan Kasarla, Chief Data Officer and Head of AI/ML; Barbara Latulippe, Takeda Head of Enterprise Data; Jennifer McGhee, MFS Investment Management Vice President, Sr. Director of Data Strategy & Governance; Cliona Molony, IDEXX Chief Data Officer, VP R&D; Raj Nimmagadda, Sanofi Chief Data Officer R&D, Data and Data Sciences; Mamta Singh, Commonwealth of Massachusetts Deputy Chief Data Officer; Jane Urban, Otsuka Pharmaceutical Companies Vice President, Customer Engagement Operations; Krishna Valluru, Fidelity Investments VP, Advanced Data Analytics; Dave McEachern, AHEAD Managing Director; Matt Sweetnam, AHEAD Managing Director; Ben Prescott, AHEAD Principal Technical Consultant – Data Science; SteveWanamaker, CDO Magazine Founder & Publisher; and Camille Prado, CDO Magazine Global Editor.